Latest Sustainability In It News

Hydrix Limited has extended its contract with Paul Hartmann AG, adding $2.8 million in revenue and reinforcing its international growth strategy.

Santos delivered a robust Q4 2024 with over US$1.4 billion in sales revenue and strong free cash flow, while progressing key LNG projects and expanding its decarbonisation initiatives.

Gryphon Capital Income Trust has announced an estimated ordinary dividend of AUD 0.0141 per unit for January 2025, payable in February. The distribution is unfranked and reflects the trust's ongoing income strategy.

Westgold Resources Limited achieved record gold production of 80,886 ounces in Q2 FY25, driving a robust net mine cash flow of $45 million and securing a $200 million corporate facility to fuel growth.

Narryer Metals has launched the next phase of exploration and metallurgical studies at its Rocky Gully project, targeting new geophysical zones and pioneering eco-friendly rare earth extraction methods.

Fortescue Metals Group has delivered its highest ever half-year iron ore shipments of 97.1 million tonnes, alongside a notable 10% reduction in hematite production costs, underscoring operational strength and advancing decarbonisation efforts.

InFocus Group Holdings reports $500,000 in cash receipts from the first phase of its VigoBet digital gaming platform contract, with the project nearing completion and promising further phases.

Parkway Corporate Limited reports a robust December quarter with a 420% revenue increase and key milestones in brine processing technology, positioning itself as a pivotal player in Queensland's CSG industry.

EZZ Life Science Holdings delivered a robust Q2 FY25 with a 16.6% increase in customer receipts and a 308% jump in operating cash flows, while gearing up for US market entry and expanding its global footprint.

Powerhouse Ventures Limited reports a robust quarterly performance with a notable uplift in net tangible assets to 10.4 cents per share, driven by strategic acquisitions and active investment management.

Imricor Medical Systems reports strong Q4 CY24 progress with successful FDA review, CE Mark submissions, and an 840% jump in consumables revenue, positioning the company for expanded global market penetration.

The Calmer Co. International Limited has reported a remarkable surge in sales and cash receipts for the first half of FY25, exceeding the entire FY24 sales. Alongside a strategic CEO transition and factory upgrade, the company is sharpening its focus on profitable growth and cost control.